메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
변준수 (서울대학교) 양동욱 (서울대학교 보건환경연구소) 손경복 (이화여자대학교) 이태진 (서울대학교)
저널정보
한국보건의료기술평가학회 보건의료기술평가 보건의료기술평가 제8권 제2호
발행연도
2020.1
수록면
100 - 105 (6page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Objectives: This study aimed to analyze the process of policy discussion related to generics, in order to investigate the cause of the low reliability of generics in Korea. Methods: This study compared the process of two policy discussions related to generics in Korea with those in the United State. One was the introduction of generic usage promotion policy such as generic substitution, and the other was the therapeutic equivalence assurance policy such as management of bioequivalence tests. Literature review was performed based on each basic research corresponding to the US and Korean cases, and we additionally reviewed documents that describe the details of the discussion at the time. Results: Discussions in the US took place openly, mainly at parliamentary hearings, and developed in a progressive direction regarding how to assure drug equivalence. On the other hand, discussions in Korea began with a limited number of people at government-affiliated committee. Even though the policy was greatly revised by opposition from the National Assembly and interest groups, it became unreliable for them. Conclusion: The main difference in the process of policy discussions between the US and Korea was transparency, which contributed to civil society’s trust and compliance with government policies, and policy development. Accordingly, it seems necessary to make the discussion process transparent, when introducing policies related to the promotion of generic usage in the future.

목차

등록된 정보가 없습니다.

참고문헌 (23)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0